SurModics, Inc.
SRDX
$37.19
$1.103.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 29.57M | 28.09M | 29.92M | 33.23M | 30.34M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.57M | 28.09M | 29.92M | 33.23M | 30.34M |
| Cost of Revenue | 16.15M | 16.20M | 16.37M | -19.98M | 18.21M |
| Gross Profit | 13.42M | 11.89M | 13.56M | 53.21M | 12.13M |
| SG&A Expenses | 12.45M | 12.55M | 12.87M | 10.88M | 13.73M |
| Depreciation & Amortization | 910.00K | 853.00K | 863.00K | 885.00K | 870.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.51M | 29.60M | 30.10M | 30.14M | 32.81M |
| Operating Income | 58.00K | -1.51M | -181.00K | 3.09M | -2.47M |
| Income Before Tax | -5.93M | -4.68M | -2.94M | -1.14M | -5.81M |
| Income Tax Expenses | -611.00K | 527.00K | 707.00K | 2.31M | 1.74M |
| Earnings from Continuing Operations | -5.32M | -5.21M | -3.65M | -3.45M | -7.55M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.32M | -5.21M | -3.65M | -3.45M | -7.55M |
| EBIT | 58.00K | -1.51M | -181.00K | 3.09M | -2.47M |
| EBITDA | 2.16M | 629.00K | 1.90M | 5.23M | -343.00K |
| EPS Basic | -0.37 | -0.36 | -0.26 | -0.24 | -0.53 |
| Normalized Basic EPS | -0.03 | -0.10 | -0.03 | 0.11 | -0.13 |
| EPS Diluted | -0.37 | -0.36 | -0.26 | -0.25 | -0.53 |
| Normalized Diluted EPS | -0.03 | -0.10 | -0.03 | 0.11 | -0.13 |
| Average Basic Shares Outstanding | 14.28M | 14.28M | 14.23M | 14.19M | 14.17M |
| Average Diluted Shares Outstanding | 14.28M | 14.28M | 14.23M | 14.19M | 14.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |